agosto 2020 – Página 120

Global Telecom Billing and Revenue Management market is expected to reach $25.22 billion by 2027

GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ — According to Stratistics MRC, the Global Telecom Billing and Revenue Management Market is accounted for $10.26 billion in 2019 and is expected to reach $25.22 billion by 2027 growing at a CAGR of 11.9% during the forecast period.

Some of the key players profiled in the Telecom Billing and Revenue Management Market include Amdocs, Netcracker, CSG Systems International, Oracle, Ericsson, Huawei, Cerillion, Mahindra Comviva, Optiva, Comarch S.A, Nokia, SAP, HPE, Openet, and Intracom Telecom.

The growing number of cellular or mobile subscribers, the evolution of CSPs to DSPs, and increasing complexities in revenue sharing across the telecom ecosystem are the major factors propelling the market growth. However, the presence of stringent telecom regulations and lack of technical proficiency in implementing billing and revenue assurance solutions are hampering the market growth.

Request for sample here: https://www.strategymrc.com/report/telecom-billing-and-revenue-management-market/request-sample

The telecom billing and revenue management solutions and services are used by various communication services providers across the world to grow their revenue by enhancing telecom networks. Such solutions and services empower the telecom service providers in fraud management and fraud detection resulting in decreased operational costs. Additionally, these telecom billing and revenue management solutions and services help telecom service providers in introducing new services in the market together with improving customer experience with real-time account recharging services. Moreover, with the rise in networks, services, and solutions, telecom operators sustain high operational costs. Therefore, growing operating costs are producing demand for advanced telecom billing and revenue management solutions.

Based on the deployment, the on-premises segment is going to have a lucrative growth during the forecast period owing to the maintenance and support, high-end IT and networking infrastructure. On-premises telecom billing and revenue management solutions are also known as customer premises solutions. This is the most demanded, traditional, and popular deployment type among operators. The majority of telecom operators stick to on-premises systems, as the infrastructure is already present and can be reused, thereby saving a substantial amount on infrastructural change.

Access the complete report at: https://www.strategymrc.com/report/telecom-billing-and-revenue-management-market

By geography, North America is going to have a lucrative growth during the forecast period due to the large-scale implementations in the telecom industry over the last decade. Some of the top companies, such as HPE and Enghouse Networks, are headquartered in North America. Mobile penetration in the region is very high. As the telecom industry in North America is more saturated than other regions, there is a high demand for telecom billing and revenue management solutions.

Make an inquiry at: https://www.strategymrc.com/report/telecom-billing-and-revenue-management-market

Types Covered:

Telecom Billing
Cloud Billing
IoT Billing

Solutions Covered:

Software
Services

Operators Covered:

Mobile Operators
Cable Network Providers
Internet Service Providers
Satellite Communication Providers

Deployments Covered:

On-Premises
Cloud
Hybrid

Organization Sizes Covered:

Small and medium-sized enterprises (SMEs)
Large Enterprises

Regions Covered:

North America

US
Canada
Mexico

Europe

Germany
France
Italy
UK
Spain
Rest of Europe

Asia Pacific

Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific

South America

Argentina
Brazil
Chile
Rest of South America

Middle East & Africa

Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:

– Market share assessments for the regional and country-level segments

– Market share analysis of the top industry players

– Strategic recommendations for the new entrants

– Market forecasts for a minimum of 9 years of all the mentioned segments, sub-segments, and the regional markets

– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)

– Strategic recommendations in key business segments based on the market estimations

– Competitive landscaping mapping the key common trends

– Company profiling with detailed strategies, financials, and recent developments

– Supply chain trends mapping the latest technological advancements

Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile

About Stratistics MRC

We offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services, and Full-Time Equivalent (FTE) services in the research world. We explore market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

Contact Info:

Name: Srikant Reddy
Email: sales@strategymrc.com
Organization: Stratistics Market Research Consulting Pvt Ltd
Phone: +1-301-202-5929
Website: https://www.strategymrc.com

View original content:http://www.prnewswire.com/news-releases/global-telecom-billing-and-revenue-management-market-is-expected-to-reach-25-22-billion-by-2027–301106598.html

SOURCE Stratistics Market Research Consulting Pvt Ltd

New IHME COVID-19 Forecasts See Nearly 300,000 Deaths by December 1, However, Consistent Mask-Wearing Could Save about 70,000 Lives

SEATTLE, Aug. 6, 2020 /PRNewswire/ — America’s COVID-19 death toll is expected to reach nearly 300,000 by December 1, however, consistent mask-wearing beginning today could save about 70,000 lives, according to new data from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine.

…

The US forecast totals 295,011 deaths by December. As of today when, thus far, 158,000 have died, IHME is projecting approximately more 137,000 deaths. However, starting today if 95% of the people in the US were to wear masks when leaving their homes, that total number would decrease to 228,271 deaths, a drop of 49%. And more than 66,000 lives would be saved.

Masks and other protective measures against transmission of the virus are essential to staying COVID-free, but people’s inconsistent use of those measures is a serious problem, said IHME Director Dr. Christopher Murray.

«We’re seeing a rollercoaster in the United States,» Murray said. «It appears that people are wearing masks and socially distancing more frequently as infections increase, then after a while as infections drop, people let their guard down and stop taking these measures to protect themselves and others – which, of course, leads to more infections. And the potentially deadly cycle starts over again.»

Murray noted that there appear to be fewer transmissions of the virus in Arizona, California, Florida, and Texas, but deaths are rising and will continue to rise for the next week or two. The drop in infections appears to be driven by the combination of local mandates for mask use, bar and restaurant closures, and more responsible behavior by the public.

«The public’s behavior had a direct correlation to the transmission of the virus and, in turn, the numbers of deaths,» Murray said. «Such efforts to act more cautiously and responsibly will be an important aspect of COVID-19 forecasting and the up-and-down patterns in individual states throughout the coming months and into next year.»

Murray said that based on cases, hospitalizations, and deaths, several states are seeing increases in the transmission of COVID-19, including Colorado, Idaho, Kansas, Kentucky, Mississippi, Missouri, Ohio, Oklahoma, Oregon and Virginia.

«These states may experience increasing cases for several weeks and then may see a response toward more responsible behavior,» Murray said.

In addition, since July 15, several states have added mask mandates. IHME’s statistical analysis suggests that mandates with no penalties increase mask wearing by 8 percentage points. But mandates with penalties increase mask wearing by 15 percentage points.

«These efforts, along with media coverage and public information efforts by state and local health agencies and others, have led to an increase in the US rate of mask wearing by about 5 percentage points since mid-July,» Murray said.

Mask-wearing increases have been larger in states with larger epidemics, he said.

IHME’s model assumes that states will reimpose a series of mandates, including non-essential business closures and stay-at-home orders, when the daily death rate reaches 8 per million. This threshold is based on data regarding when states and/or communities imposed mandates in March and April, and implies that many states will have to reimpose mandates.

As a result, the model suggests which states will need to reimpose mandates and when:

August – Arizona, Florida, Mississippi, and South Carolina
September – Georgia and Texas
October – Colorado, Kansas, Louisiana, Missouri, Nevada, North Carolina, Oregon, and Washington.
November – Alabama, Arkansas, California, Iowa, New Mexico, Oklahoma, Utah, and Wisconsin.

However, if mask use is increased to 95%, the re-imposition of stricter mandates could be delayed 6 to 8 weeks on average.

The model also assumes that that 50% of school districts in each state will opt for online instruction only for the 2020–2021 school year.

«As data emerge on actual school patterns, we will incorporate them into our future revisions of forecasts,» Murray said. «We recognize that, given mask wearing, the likely restrictions on after-school activities, and the potential for some parents to avoid engaging in school-related functions, our estimated impact of school openings may be overly pessimistic.»

The new death projections and other information, such as hospital resources usage, are available at https://covid19.healthdata.org.

IHME wishes to warmly acknowledge the support of these and others who have made our COVID-19 estimation efforts possible.

About the Institute for Health Metrics and Evaluation
The Institute for Health Metrics and Evaluation (IHME) is an independent global health research organization at the University of Washington School of Medicine that provides rigorous and comparable measurement of the world’s most important health problems and evaluates the strategies used to address them. IHME is committed to transparency and makes this information widely available so that policymakers have the evidence they need to make informed decisions on allocating resources to improve population health.

View original content to download multimedia:http://www.prnewswire.com/news-releases/new-ihme-covid-19-forecasts-see-nearly-300-000-deaths-by-december-1–however-consistent-mask-wearing-could-save-about-70-000-lives-301107858.html

SOURCE Institute for Health Metrics and Evaluation

Tindall Corporation’s Utility Division Provides Precast Bridge for Chestnut Mountain Ranch

SPARTANBURG, S.C., Aug. 6, 2020 /PRNewswire-PRWeb/ — «Tindall is a company who has a heart for serving others,» said Steve Finn, Founder and Executive Director of Chestnut Mountain Ranch. «Their team’s leadership is always looking for opportunities to make things better than the way they found them, and we are beyond grateful for their partnership and contributions that support the mission of Chestnut Mountain Ranch.»

Tindall’s CEO, Greg…

Tindall’s CEO, Greg Force, expressed his personal appreciation to Joel Sheets and his team for the innovative solution provided, as well as to Bill Swofford, Manager of Tindall Haul and Erect, for hauling the beams to the site. «As a company, we are blessed to have the opportunity to support the work of Chestnut Mountain Ranch in making a positive difference in the lives of boys going through difficult circumstances. That this bridge will allow the construction of a chapel for the Ranch is an offered prayer God will work richly in the lives of the boys and the staff in the years to come.»

Established in 2005, Chestnut Mountain Ranch is a Christian home and school for boys in need of hope and healing. Steve Finn and his family developed a program geared to help children develop spiritually, intellectually and socially through guidance in education and relationships. The organization continues to expand its facilities through the construction of new homes and the chapel. Support the Chestnut Mountain Ranch mission by volunteering or donating. Learn how at https://cmrwv.org/get-involved/.

To learn more about Tindall Corporation, visit https://tindallcorp.com/.

About Tindall
Headquartered in Spartanburg, S.C., Tindall Corporation is one of the largest precast concrete manufacturers in North America. With five production facilities located throughout the Mid-Atlantic, Southeastern, and South-Central United States, Tindall provides engineering, manufacturing, shipping and installation solutions for precast, prestressed concrete systems and underground utility structures.

SOURCE Tindall Corporation

Blue Shield of California y Cricket Health colaboran a fin de transformar la atención renal para los miembros

OAKLAND, Calif., 6 de agosto de 2020 /PRNewswire-HISPANIC PR WIRE/ — Blue Shield of California y Cricket Health anunciaron hoy un nuevo programa innovador, personalizado e integral enfocado en la coordinación de la atención para los miembros afectados por una enfermedad renal crónica en etapa avanzada o una enfermedad renal en etapa terminal sin costo adicional para ellos.

<img id="prnejpg515dleft"…

A través de la colaboración a largo plazo, Cricket Health ofrecerá un equipo de atención multidisciplinaria que incluye enfermeros, farmacéuticos, trabajadores sociales, dietistas y mentores quienes están capacitados para ofrecer un enfoque basado en los conocimientos científicos y médicos para ayudar a los pacientes a controlar mejor su enfermedad renal crónica o enfermedad renal en etapa terminal.

El equipo, disponible en línea y por teléfono, trabaja en estrecha colaboración con los proveedores médicos de los miembros participantes, incluidos los médicos de atención primaria, nefrólogos y otros especialistas, para garantizar que, en la medida de lo posible, el paciente se mantenga sano, en su casa y fuera del hospital. El programa es especialmente relevante en el entorno actual creado por el Covid-19, y está disponible para los miembros inscritos en los planes PPO (siglas en inglés de «preferred provider organization» u organización de proveedores preferidos) con cobertura total de Blue Shield.

«Reconocemos que, durante demasiado tiempo, el sistema de salud de los Estados Unidos no ha logrado ofrecer una atención médica de la más alta calidad a un costo accesible a los pacientes que sufren de enfermedades renales, los cuales suman unos 37 millones de personas», dijo el Dr. Seth Glickman, director de salud de Blue Shield of California. «Al colaborar con Cricket Health, podemos reimaginar el cuidado de los riñones y expandir las opciones de atención médica para los miembros afectados por una enfermedad renal crónica en etapa avanzada o una enfermedad renal en etapa final, de manera que puedan vivir de la forma más saludable posible».

Los datos de los reclamos de Blue Shield y las capacidades avanzadas de análisis de datos de Cricket se utilizan para identificar a los miembros que tienen una enfermedad renal crónica o corren riesgos de contraerla, y Cricket los invita a participar en el programa. Una vez inscritos, Cricket Health asignará un equipo de atención multidisciplinaria y programas virtuales con el objetivo de disminuir el avance de la enfermedad, reducir las complicaciones de salud y evitar las visitas a la sala de emergencias o las hospitalizaciones.

Al intervenir mucho antes de que se produzca la insuficiencia renal, Cricket Health puede ofrecer un plan de atención renal personalizado y probado para cada paciente que mejora su estado de salud. En el caso de los miembros con estados avanzados de enfermedad renal, Cricket Health les explicará sus opciones de tratamiento, como diálisis en un centro médico o un trasplante, y los apoyará en su opción preferida.

«Esta colaboración cambiará fundamentalmente lo que el diagnóstico de una enfermedad renal significa para los pacientes, dándoles el control en su cuidado renal», dijo Arvind Rajan, director ejecutivo de Cricket Health. «Nuestro enfoque integral en la atención de la enfermedad renal crónica y la enfermedad renal en etapa terminal incluye los cuidados preventivos, la disminución del avance de la enfermedad y, en los casos necesarios, el tratamiento adecuado para ellos. Junto con Blue Shield, apoyaremos a los miembros con un equipo de atención multidisciplinaria que visitará a los pacientes en la seguridad y comodidad de sus hogares».

Este servicio llega en un momento crítico, ya que las personas que padecen una enfermedad renal crónica o una enfermedad renal en etapa terminal tienen un riesgo más alto de sufrir complicaciones por el Covid-19. Al ofrecer atención a distancia, por teléfono o virtualmente en línea, el enfoque de Cricket Health en materia de atención renal tiene como objetivo asegurar que los miembros de Blue Shield que tienen enfermedades renales estén saludables en sus casas y fuera de las clínicas u hospitales siempre que sea posible.

Esta innovadora atención renal es el último ejemplo de la iniciativa Health Reimagined de Blue Shield of California enfocada en la transformación del sistema de atención médica para las personas, las familias y las comunidades y también aborda las desigualdades en materia de salud comunes entre las comunidades minoritarias. Las enfermedades renales afectan a las comunidades de color de manera desproporcionada y la colaboración de Blue Shield con Cricket Health busca expandir el acceso a la atención renal de calidad.

Acerca de Cricket Health
Cricket Health es un proveedor de cuidados renales integrales con un enfoque personalizado y basado en los conocimientos científicos y médicos para el control de la enfermedad renal crónica y la enfermedad renal en etapa terminal. Cricket trabaja con los pagadores y los proveedores para identificar a los pacientes que están en riesgo, actúa de manera temprana para disminuir el avance de la enfermedad y ofrece un cuidado renal personalizado y enfocado en el paciente a través de un equipo multidisciplinario de atención. Si un paciente sufre de una enfermedad renal en etapa terminal, Cricket lo educa acerca de sus opciones de tratamiento y le brinda un cuidado personalizado, ya sea que se trate de apoyo para un trasplante, diálisis en el hogar, atención conservadora o diálisis en un centro médico. Fundada en 2015 y con sede en San Francisco y Cambridge, los directivos de la compañía incluyen a algunos de los principales expertos en nefrología, atención médica y tecnología.

Obtenga más información en www.crickethealth.com o síganos en @crickethealth.

Acerca de Blue Shield of California
Blue Shield of California está dedicada a crear un sistema de salud no sólo digno de su familia y amigos sino además sosteniblemente económico. La organización no lucrativa tiene un estado tributario no exento, es un miembro independiente de Blue Cross Blue Shield Association y cuenta con 4 millones de clientes, 6,800 empleados y más de $20 mil millones en ingresos anuales. Fundada en 1939 en San Francisco y con sede actual en Oakland, Blue Shield of California y sus subsidiarias ofrecen planes de salud para cuidados médicos, dentales, de la vista, Medicaid y Medicare en California. Desde 2002, la compañía donó más de $500 millones a la Fundación Blue Shield of California para el beneficio de las comunidades de California.

Para leer más noticias acerca de Blue Shield of California, visite nuestro Centro de noticias en español en https://es.news.blueshieldca.com/.

O síganos en LinkedIn, Twitter o Facebook

CONTACTO:	Mashi Nyssen
	Blue Shield of California
	510-607-2359
	media@blueshieldca.com

Logo – https://mma.prnewswire.com/media/810201/blue_jpg_Logo.jpg

FUENTE Blue Shield of California

KRKR Alert: Johnson Fistel Launches Investigation into 36Kr – Investors Suffering Losses Encouraged to Contact the Firm

SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against 36Kr Holdings Inc. («36Kr» or the «Company») (NASDAQ: KRKR) for violations of federal securities laws.

On or about November 8, 2019, 36Kr sold about 1.4 million shares of stock in its initial public stock offering (the «IPO»), at $14.50 a share raising nearly $20.5 million in new capital. However, since…

Specifically, Johnson Fistel’s investigation seeks to determine whether the Company’s filings with the U.S. Securities and Exchange Commission in connection with its November 2019 IPO and subsequent investor communications contained untrue statements of material facts or omitted to state other facts necessary to make the statements made therein not misleading concerning the Company’s business, and operations.

If you have information that could assist in this investigation, or if you are a 36Kr shareholder and are interested in learning more about the investigation, please contact Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [Click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

[Click here to join this action]

View original content:http://www.prnewswire.com/news-releases/krkr-alert-johnson-fistel-launches-investigation-into-36kr—investors-suffering-losses-encouraged-to-contact-the-firm-301107861.html

SOURCE Johnson Fistel, LLP

Pomerantz Law Firm Announces the Filing of a Class Action against Airbus SE and Certain Officers – EADSY; EADSF

NEW YORK, Aug. 6, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Airbus SE («Airbus» or the «Company») (OTCMKTS: EADSY; EADSF) and certain of its officers. The class action, filed in United States District Court for the District of New Jersey, and indexed under 20-cv-10084, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise, acquired Airbus securities in the U.S. between February 24, 2016, and July 30, 2020, both dates inclusive (the «Class Period»), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the «Exchange Act») and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Airbus securities during the class period, you have until October 5, 2020 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

[Click here for information about joining the class action]

Airbus was founded in 2000 and is based in Leiden, the Netherlands. The Company is a multinational aerospace corporation, operating through its Commercial Aircraft, Defense and Space, and Helicopters divisions. The Company’s American Depository Receipts («ADRs») trade in the U.S. on the over-the-counter market (the «OTC») under the ticker symbol «EADSY,» and the Company’s foreign ordinary shares («foreign ordinaries») trade in the U.S. on the OTC under the ticker symbol «EADSF.»

In August 2012, the United Kingdom («U.K.») Serious Fraud Office («SFO») announced that it had opened a formal criminal investigation into one of Airbus’s subsidiaries, GPT Special Project Management Ltd. («GPT»), which Airbus acquired in 2007. The allegations called into question a service contract entered into by GPT prior to its acquisition by Airbus, relating to activities conducted by GPT in Saudi Arabia.

Unbeknownst to investors and the public, however, Airbus was at an increased and foreseeable risk of facing significant potential liabilities for other alleged illegal activities that would later be investigated by governmental authorities around the world. These activities, combined with the investigation into GPT, implicated all three of Airbus’s divisions, calling into question the sustainability of the Company’s reported earnings during the Class Period.

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose: (i) that Airbus’s policies and protocols were insufficient to ensure the Company’s compliance with relevant anti-corruption laws and regulations; (ii) that, consequently, Airbus engaged in bribery, corruption, and fraud in order to enhance its business with respect to its commercial aircraft, helicopter, and defense deals; (iii) that, as a result, Airbus’s earnings were derived in part from unlawful conduct and therefore unsustainable; (iv) the full scope and severity of Airbus’s misconduct; (v) that resolution of government investigations of Airbus would foreseeably cost Airbus billions of dollars in settlements and legal fees and subject the Company to significant continuing government investigation and oversight; and (vi) that, as a result, the Company’s public statements were materially false and misleading at all relevant times.

On August 8, 2016, Reuters reported that the U.K. had opened a corruption probe into Airbus. Specifically, the SFO announced that it had «opened a criminal investigation into allegations of fraud, bribery, and corruption in the civil aviation business of Airbus,» which «relate to irregularities concerning third party consultants.» The investigation followed Airbus’s flagging of «misstatements and omissions» involving outside contractors in certain export financing applications to U.K. regulators and the European Export Credit Agencies earlier in the year, which the Company had found through an internal probe.

On this news, Airbus ADRs fell $0.21 per share, or 1.49%, to close at $13.86 per share on August 8, 2016, and Airbus foreign ordinaries fell $0.82 per share, or 1.45%, to close at $55.58 per share on August 8, 2016.

France and the U.S. later opened their investigations into the subject of the SFO’s allegations in 2017 and 2018, respectively. On January 31, 2020, media outlets reported that Airbus had agreed to a deal with U.S., U.K., and French prosecutors to settle bribery and export-control violations against the Company for €3.6 billion ($4 billion). Pursuant to the settlement, Airbus also agreed to appoint an external compliance officer for at least two years to monitor the Company’s handling of its defense-related sales and disclosures.

On this news, Airbus ADRs fell $0.72 per share, or 1.93%, to close at $36.68 per share on January 31, 2020, and Airbus foreign ordinaries fell $2.21 per share, or 1.48%, to close at $147.00 per share on January 31, 2020.

Then, on March 15, 2020, the Wall Street Journal reported that Airbus executives had previously raised red flags about fees paid to a number of middlemen working with its helicopter division, led at the time by the Company’s current Chief Executive Officer («CEO»), Defendant Guillaume M.J.D. Faury («Faury»), that may have violated global bribery and corruption rules, according to internal documents related to Airbus’s $4 billion bribery settlement, which were not previously made public and/or reported.

On this news, Airbus ADRs fell $3.44 per share, or 15.71%, to close at $18.46 per share on March 16, 2020, and Airbus foreign ordinaries fell $7.97 per share, or 9.3%, to close at $77.75 per share on March 16, 2020.

Finally, on July 30, 2020, the Wall Street Journal reported that the SFO had charged GPT and three individuals with corruption in connection with a defense contract the U.K. had arranged with Saudi Arabia. These charges were the culmination of the investigations initiated by the SFO back in August 2012.

On this news, Airbus ADRs fell $0.67 per share, or 3.56%, to close at $18.13 per share on July 31, 2020, and Airbus foreign ordinaries fell $2.85 per share, or 3.8%, to close at $72.10 per share on July 31, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

View original content:http://www.prnewswire.com/news-releases/pomerantz-law-firm-announces-the-filing-of-a-class-action-against–airbus-se-and-certain-officers–eadsy-eadsf-301107810.html

SOURCE Pomerantz LLP

Celgard sale triunfante en tribunal del Reino Unido y se le otorga requerimiento judicial contra importaciones de separadores de baterías de Senior mediante juicio

CHARLOTTE, Carolina del Norte, 6 de agosto de 2020 /PRNewswire/ — Después de la concesión del tribunal del Reino Unido de un requerimiento judicial interino el 7 de mayo de 2020 contra Shenzhen Senior Technology Material Co., Ltd. (Senior) como lo solicitó Celgard, LLC (Celgard), una subsidiaria de Polypore International, LP (Polypore), y la orden del tribunal del Reino Unido del 21 de mayo de 2020 continuando el efecto del requerimiento judicial interino, el tribunal del Reino Unido emitió un fallo el 30 de julio de 2020 que…

El fallo del tribunal a favor de Celgard no solo otorgó el requerimiento judicial contra Senior, sino que también mantuvo que Celgard había establecido como una cuestión grave para ser juzgada que Senior había usado sus secretos comerciales en el desarrollo y la fabricación de separadores de baterías y que Inglaterra era el foro apropiado para la disputa sobre la importación. Celgard tiene el propósito de llevar hasta las últimas consecuencias su caso sobre secreto comercial contra Senior.

El 30 de abril de 2020, Celgard presentó una solicitud para un requerimiento judicial urgente contra Senior en el Alto Tribunal de Justicia en Londres, Inglaterra. El 7 de mayo, a beneficio de una sola parte, el tribunal del Reino Unido otorgó un requerimiento judicial para evitar que Senior importe ciertos separadores de baterías al Reino Unido.

Antes, el 2 de marzo, Celgard interpuso una Demanda contra los Demandados Shenzhen Senior Technology Material Co. Ltd. (Senior-China), Shenzhen Senior Technology Material Co. Ltd. (EE.UU.) Research Institute (Senior-California), Xiaomin (Steven) Zhang, Sun Town Technology, Inc., Global Venture Development, LLC, y Global Venture Development, Inc. (colectivamente, Global Venture) (colectivamente, Demandados en el WDNC) en el Tribunal de Distrito de los EE.UU. por el Distrito Oeste de Carolina del Norte (WDNC) por apropiación indebida de secreto comercial, prácticas comerciales desleales y engañosas y competencia desleal, conspiración civil, enriquecimiento injusto y conversión.

Además, Celgard interpuso una Segunda Demanda Enmendada contra los Demandados, incluidos Shenzhen Senior Technology Material Co. Ltd. (EE.UU.), Research Institute (Senior-California) y otros (colectivamente, Demandados en el NDCA) por infracción de patente, incumplimiento de contrato e incumplimiento de convenio implícito de buena fe y trato equitativo en el Tribunal de Distrito de los EE.UU. por el Distrito Norte de California (NDCA).

La Demanda del WDNC alega que los Demandados en el WDNC, entre ellos un ex empleado de Celgard, Xiaomin (Steven) Zhang, ahora director de Tecnología de Senior-China, quien se cambió el nombre a Bin Wang a solicitud de Senior-China, se apropiaron a propósito e ilegalmente de secretos comerciales e información confidencial de Celgard y continúan haciéndolo. También se alegan otras infracciones de la ley.

La Segunda Demanda Enmendada del NDCA alega que los Demandados en el NDCA infringen la Patente Estadounidense Reemitida de Celgard RE47,520 (la patente ‘520), anteriormente la Patente Estadounidense 6,432,586 (la patente ‘586), y la Patente Estadounidense de Celgard No. 6,692,867 (la patente ‘867). Ver el Comunicado.

En diciembre de 2019, Celgard interpuso una Primera Demanda Enmendada en el NDCA, agregando a la demanda a los Demandados Farasis, Sun Town y Global Venture. Ver el Comunicado.

En septiembre de 2019, Celgard interpuso una demanda contra Senior, que vende separadores internacionalmente que fabrica en Shenzhen, China. La Demanda de Celgard alegó que Senior había infringido las patentes estadounidenses ‘520 y ‘867 de Celgard, y que se ha apropiado ilegalmente y ha hecho un mal uso de secretos comerciales e información confidencial de Celgard, entre otras infracciones, y busca compensación por daños y perjuicios. Ver el Comunicado.

En septiembre de 2019, Celgard resolvió exitosamente una demanda por infracción de patente contra Targray International. Ver el Comunicado. Celgard también resolvió exitosamente dos demandas en junio de 2019 contra MTI Corporation. Ver el Comunicado.

El fallo en el Reino Unido y el resultado exitoso de los casos contra Targray y MTI consolida aún más la integridad de la propiedad intelectual (PI) de Celgard sobre separadores con revestimiento y sin revestimiento para baterías de iones de litio. Celgard seguirá evitando la explotación injusta de su tecnología y su PI para proteger sus activos y a sus clientes.

Acerca de Celgard y Polypore

Celgard se especializa en membranas microporosas de proceso seco, con revestimiento o sin revestimiento, usadas como separadores, que son un componente importante de las baterías de iones de litio. La tecnología de separadores de baterías de Celgard es importante para el rendimiento de las baterías de iones de litio para vehículos eléctricos, sistemas de almacenamiento de energía y otras aplicaciones.

Celgard, LLC es una subsidiaria de propiedad total de Polypore International, LP, una compañía de Asahi Kasei.

Polypore es una empresa internacional con instalaciones en nueve países, que se especializa en membranas microporosas utilizadas en vehículos eléctricos y no eléctricos, sistemas de almacenamiento de energía y aplicaciones especiales. Visite www.celgard.com y www.polypore.com.

Foto – https://mma.prnewswire.com/media/1224868/Celgard.jpg
Logo – https://mma.prnewswire.com/media/798399/PolyPore_Logo.jpg

FUENTE Polypore International, LP

Celgard sale triunfante en tribunal del Reino Unido y se le otorga requerimiento judicial contra importaciones de separadores de baterías de Senior mediante juicio

En diciembre de 2019, Celgard interpuso una Primera Demanda Enmendada en el NDCA, agregando a la demanda a los Demandados Farasis, Sun Town y Global Venture. Ver el Comunicado.

Acerca de Celgard y Polypore

Celgard, LLC es una subsidiaria de propiedad total de Polypore International, LP, una compañía de Asahi Kasei.

Foto – https://mma.prnewswire.com/media/1224868/Celgard.jpg
Logo – https://mma.prnewswire.com/media/798399/PolyPore_Logo.jpg

FUENTE Polypore International, LP

Celgard sale triunfante en tribunal del Reino Unido y se le otorga requerimiento judicial contra importaciones de separadores de baterías de Senior mediante juicio

En diciembre de 2019, Celgard interpuso una Primera Demanda Enmendada en el NDCA, agregando a la demanda a los Demandados Farasis, Sun Town y Global Venture. Ver el Comunicado.

Acerca de Celgard y Polypore

Celgard, LLC es una subsidiaria de propiedad total de Polypore International, LP, una compañía de Asahi Kasei.

Foto – https://mma.prnewswire.com/media/1224868/Celgard.jpg
Logo – https://mma.prnewswire.com/media/798399/PolyPore_Logo.jpg

FUENTE Polypore International, LP

Celgard sale triunfante en tribunal del Reino Unido y se le otorga requerimiento judicial contra importaciones de separadores de baterías de Senior mediante juicio

En diciembre de 2019, Celgard interpuso una Primera Demanda Enmendada en el NDCA, agregando a la demanda a los Demandados Farasis, Sun Town y Global Venture. Ver el Comunicado.

Acerca de Celgard y Polypore

Celgard, LLC es una subsidiaria de propiedad total de Polypore International, LP, una compañía de Asahi Kasei.

Foto – https://mma.prnewswire.com/media/1224868/Celgard.jpg
Logo – https://mma.prnewswire.com/media/798399/PolyPore_Logo.jpg

FUENTE Polypore International, LP